Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “28 Day Mortality”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableLooking for participantsNCT07230067
What this trial is testing

Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）

Who this might be right for
SepsisSepsis and Coagulopathy
Nanfang Hospital, Southern Medical University 1,500
Not applicableUnknownNCT03511742
What this trial is testing

Functional ICUS in Uganda and Their Survival Outcomes

Who this might be right for
Critical Illness
Makerere University 367
Not applicableUnknownNCT03800849
What this trial is testing

Mechanical Ventilation Practices in Uganda's Intensive Care Units

Who this might be right for
Mechanically Ventilated Patients
Makerere University 214
Large-scale testing (Phase 3)Ended earlyNCT00037687
What this trial is testing

Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis

Who this might be right for
Sepsis
ICOS Corporation 2,500
Not applicableStudy completedNCT07433127
What this trial is testing

Inflammation Indıces and Mortality in Adult Crush Syndrome

Who this might be right for
Crush SyndromeRhabdomyolysisSystemic Inflammatory Response+1 more
Ataturk University 325
Not applicableUnknownNCT04747106
What this trial is testing

Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on-chronic Liver Failure

Who this might be right for
28 Day Mortality
Nanfang Hospital, Southern Medical University 390
Not applicableStudy completedNCT05276921
What this trial is testing

Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients

Who this might be right for
Sarcopenia ICU Ultrasound
Centre Hospitalier Universitaire Dijon 150
Testing effectiveness (Phase 2)UnknownNCT01849237
What this trial is testing

Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

Who this might be right for
Septic ShockNonchemotherapy Drug-induced NeutropeniaNeutropenia After Chemotherapy in Oncohematological Patients+1 more
National Research Center for Hematology, Russia 30
Not applicableStudy completedNCT07196891
What this trial is testing

Predictive Role of f-QRST Angle in Subarachnoid Hemorrhage

Who this might be right for
Subarachnoid Hemorrhage, Aneurysmal
Haseki Training and Research Hospital 354
Not applicableUnknownNCT04915625
What this trial is testing

A Prediction Model of 28-day Mortality in Septic Shock

Who this might be right for
Septic Shock
Second Affiliated Hospital, Zhejiang University, School of Medicine 530
Not applicableUnknownNCT05126537
What this trial is testing

Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis

Who this might be right for
28 Day Mortality
Southeast University, China 100
Large-scale testing (Phase 3)UnknownNCT02707497
What this trial is testing

The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia

Who this might be right for
SepsisThrombocytopenia
Ruilan Wang 200
Not applicableStudy completedNCT07819708
What this trial is testing

Comparing Blood-Based Ratios for Predicting Outcomes in Sepsis and Septic Shock

Who this might be right for
SepsisSeptic Shock
Benha University 60
Not applicableStudy completedNCT06111248
What this trial is testing

Impact of Training on the Use of Software and Digital Monitoring Tools During General Anesthesia for Intermediate/Major-risk Surgery on Morbidity and Mortality at 28 Days

Who this might be right for
All Conditions Requiring Non-cardiac Surgery
Centre Hospitalier Universitaire de Nīmes 1,028